Arterial hypertension (BASKET) Bibliography of free accessible medical and biological reviews

Nr.	Year OPEN	Title	rate good	rate bad	no link	Citation
1	1978	Nonpharmacologic control of essential hypertension in man: a critical review of the experimental literature.	+	-	nl	Psychosom Med 40(4):294-320 (1978)
2	1978	Relaxation methods and the control of blood pressure.	+	-	nl	Psychosom Med 40(4):273-5 (1978)
3	2001	ABC of hypertension: The pathophysiology of hypertension.	+	-	nl	BMJ 322(7291):912-6 (2001)
4	1965	Hyperpiesis: high blood-pressure without evident cause: essential hypertension.	+	-	nl	Br Med J 2(5469):1021-6 concl (1965)
5	1965	Hyperpiesis; high blood-pressure without evident cause: essential hypertension.	+	-	nl	Br Med J 2(5468):959-68 contd (1965)
6	2010	Angiotensin receptor blockers for management of hypertension.	+	-	nl	South Med J 103(7):669-73 (2010) Catanzaro DF
7	2010	Angiotensin-receptor blockers for the management of hypertension: new insights, new challenges.	+	-	nl	South Med J 103(7):599-600 (2010) Saha SA
8	2009	Angiotensin receptor blockers: role in hypertension management, cardiovascular risk reduction, and nephropathy.	+	-	nl	South Med J 102(10 Suppl):S1-S12 (2009) Basile J
9	2008	Resistant hypertension: identifying causes and optimizing treatment regimens.	+	-	nl	South Med J 101(2):166-73 (2008) Trewet CL
10	2007	Rationale for combination therapy in hypertension management: focus on angiotensin receptor blockers and thiazide diuretics.	+	-	nl	South Med J 100(4):386-92 (2007) Nash DT
11	2001	Antihypertensive medications.	+	-	nl	South Med J 94(11):1071-3 (2001)
12	2001	Hypertension. Medication update.	+	-	nl	South Med J 94(11):1065-70 (2001)
13	2000	Pitfalls in the diagnosis and management of systolic hypertension.	+	-	nl	South Med J 93(3):256-9 (2000)
14	2000	Controlling hypertension in the elderly.	+	-	nl	QJM 93(4):203-5 (2000)
15	1999	Management of hypertension in patients developing end-stage renal failure.	+	-	nl	QJM 92(9):519-25 (1999)
16	2003	Hypertension: a review of therapeutic options.	+	-	nl	Manag Care 12(8 Suppl Hypertension):34-44 (2003) Carter BL
17	1999	Severe paroxysmal hypertension (pseudopheochromocytoma): understanding the cause and treatment.	+	-	nl	Arch Intern Med 159(7):670-4 (1999)
18	2004	Baroreflex failure: a neglected type of secondary hypertension.	+	-	nl	Neth J Med 62(5):151-5 (2004) Timmers HJ
19	2003	New developments in the treatment of hypertension: are some antihypertensives more equal than others?	+	-	nl	Neth J Med 61(5 Suppl):13-8 (2003) Gansevoort RT
20	2009	Beta-blockers for hypertension: are they going out of style?	+	-	nl	Cleve Clin J Med 76(9):533-42 (2009) Che Q
21	2008	What is the proper workup of a patient with hypertension?	+	-	nl	Cleve Clin J Med 75(9):663-72 (2008) Katakam R
22	2007	A different approach to resistant hypertension.	+	-	nl	Cleve Clin J Med 74(6):449-56 (2007) Hirsch S
23	1979	Pathogenesis of hypertensive retinopathy: a review.	+	-	nl	J R Soc Med 72(5):362-5 (1979)
24	2007	Rebuttal: Do beta-blockers have a role in treating hypertension? Yes.	+	-	nl	Can Fam Physician 53(5):800-3 (2007) Khan N
25	2007	Do beta-blockers have a role in treating hypertension? No.	+	-	nl	Can Fam Physician 53(4):614-21 (2007) McCormack JP
26	2007	Do beta-blockers have a role in treating hypertension? Yes.	+	-	nl	Can Fam Physician 53(4):614-21 (2007) Khan N
27	1998	Echocardiography for primary care evaluation of hypertension.	+	-	nl	Can Fam Physician 44(-):2702-6 (1998)
28	2003	Clinical review: the management of hypertensive crises.	+	-	nl	Crit Care 7(5):374-84 (2003) Varon J
29	2003	Hypertension in the critically ill patient.	+	-	nl	Crit Care Resusc 5(1):24-42 (2003) Santhi R
30	2000	Diagnosis and treatment of hypertension in children and adolescents.	+	-	nl	Can J Cardiol 16(6):801-11 (2000)
31	1996	Resistant hypertension: an overview.	+	-	nl	Can J Cardiol 12(9):822-8 (1996)
32	2003	Calcium antagonists in patients with type 2 diabetes and hypertension.	+	-	nl	Cardiovasc Drug Rev 21(2):105-18 (2003) McFarlane SI
33	2010	Is it time to target prehypertension.	+	-	nl	Cardiovasc Ther 28(6):337-8 (2010) Whaley-Connell A
34	2011	5-hydroxtryptamine receptors in systemic hypertension: an arterial focus.	+	-	nl	Cardiovasc Ther 29(1):54-67 (2011) Watts SW
35	2009	Hypertension in the very elderly: Brief review of management.	+	-	nl	Cardiol J 16(4):379-85 (2009) Zeglin MA
36	2008	Hypertension and microvascular remodelling.	+	-	nl	Cardiovasc Res 78(2):274-85 (2008) Feihl F
37	2006	Redox signaling in hypertension.	+	-	nl	Cardiovasc Res 71(2):247-58 (2006) Paravicini TM
38	2004	Interactions between the sympathetic nervous system and the kidneys in arterial hypertension.	+	-	nl	Cardiovasc Res 61(2):238-46 (2004) Grisk O
39	2002	Sex hormones and hypertension.	+	-	nl	Cardiovasc Res 53(3):688-708 (2002)
40	2000	The influence of antihypertensive drug treatment on the prevention and regression of left ventricular hypertrophy.	+	-	nl	Cardiovasc Res 45(1):82-91 (2000) van Zwieten PA
41	1987	The large studies in hypertension: what have they shown?	+	-	nl	Br J Clin Pharmacol 24 Suppl 1(-):3S-14S (1987)
42	1986	The management of hypertension.	+	-	nl	Br J Clin Pharmacol 21 Suppl 2(-):129S-142S (1986)
43	1986	Salt and hypertension.	+	-	nl	Br J Clin Pharmacol 21 Suppl 2(-):123S-128S (1986)
44	1980	Pharmacology of centrally acting hypotensive drugs.	+	-	nl	Br J Clin Pharmacol 10 Suppl 1(-):13S-20S (1980)
45	2005	The vanilloid receptor and hypertension.	+	-	nl	Acta Pharmacol Sin 26(3):286-94 (2005) Wang DH
46	2007	Case study: pearls in hypertension pharmacotherapy.	+	-	nl	J Manag Care Pharm 13(5 Suppl):S13-6 (2007) Cohen JD
47	2007	Overview of physiology, vascular biology, and mechanisms of hypertension.	+	-	nl	J Manag Care Pharm 13(5 Suppl):S6-8 (2007) Cohen JD
48	2010	Exforge (amlodipine/valsartan combination) in hypertension: the evidence of its therapeutic impact.	+	-	nl	Core Evid 4():1-11 (2010) Krzesinski JM
49	2000	Clinical overview of antihypertensive classes--clinically relevant differences: myths or facts? Based on a presentation by Alan H. Gradman, MD.	+	-	nl	Am J Manag Care 6(4 Suppl):S197-210 (2000)
50	1979	The hypertensive patient: 1. Is treatment beneficial?	+	-	nl	Can Med Assoc J 120(11):1319-20 (1979)
51	1979	Membranes and bile formation. Composition of several mammalian biles and their membrane-damaging properties.	+	-	nl	Biochem J 178(1):201-8 (1979)
52	1975	Aldosterone and renin in essential hypertension.	+	-	nl	Can Med Assoc J 113(5):421-31 (1975)
53	1965	NEWER DRUGS IN THE TREATMENT OF HYPERTENSION.	+	-	nl	Can Med Assoc J 92(-):918-22 (1965)
54	2007	Hypertensive crises: challenges and management.	+	-	nl	Chest 131(6):1949-62 (2007) Marik PE
55	2000	The diagnosis and management of hypertensive crises.	+	-	nl	Chest 118(1):214-27 (2000)
56	1988	Calcium antagonists in the treatment of hypertension. An overview.	+	-	nl	Chest 93(6):1251-3 (1988)
57	2008	Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.	+	-	nl	Circulation 117(25):e510-26 (2008) Calhoun DA
58	2008	Risk/benefit assessment of beta-blockers and diuretics precludes their use for first-line therapy in hypertension.	+	-	nl	Circulation 117(20):2706-15; discussion 2715 (2008) Messerli FH
59	2008	Thiazide-type diuretics and beta-adrenergic blockers as first-line drug treatments for hypertension.	+	-	nl	Circulation 117(20):2691-704; discussion 2705 (2008) Cutler JA
60	2007	Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention.	+	-	nl	Circulation 115(21):2761-88 (2007) Rosendorff C
61	2006	Preventing vascular events due to elevated blood pressure.	+	-	nl	Circulation 113(18):2166-8 (2006) Yusuf S
62	2005	Natural history of hypertension subtypes.	+	-	nl	Circulation 111(9):1094-6 (2005) Verdecchia P
63	2004	Hypertensive therapy: Part II.	+	-	nl	Circulation 109(25):3081-8 (2004) Franco V
64	2004	Hypertensive therapy: Part I.	+	-	nl	Circulation 109(24):2953-8 (2004) Franco V
65	2002	Evaluation and treatment of patients with systemic hypertension.	+	-	nl	Circulation 105(21):2458-61 (2002)
66	2000	New issues in the treatment of isolated systolic hypertension.	+	-	nl	Circulation 102(10):1079-81 (2000)
67	2000	Essential hypertension : part II: treatment.	+	-	nl	Circulation 101(4):446-53 (2000)
68	2000	Essential hypertension. Part I: definition and etiology.	+	-	nl	Circulation 101(3):329-35 (2000)
69	2005	Management of hypertension in elderly diabetic patients.	+	-	nl	Diabetes Metab 31 Spec No 2():5S82-5S91 (2005) Blickle JF
70	2008	Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials.	+	-	nl	Eur Heart J 29(21):2669-80 (2008) Turnbull F
71	2007	2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).	+	-	nl	Eur Heart J 28(12):1462-536 (2007) Mancia G
72	2000	Hypertensive heart disease. A complex syndrome or a hypertensive 'cardiomyopathy'?	+	-	nl	Eur Heart J 21(20):1653-65 (2000)
73	1999	Treatment with beta-blockers for the primary prevention of the cardiovascular complications of hypertension.	+	-	nl	Eur Heart J 20(1):11-24 (1999) Staessen JA
74	2003	Cardiac and vascular pathophysiology in hypertension.	+	-	nl	Heart 89(9):1104-9 (2003) Mayet J
75	2001	Essential hypertension: the heart and hypertension.	+	-	nl	Heart 86(4):467-75 (2001)
76	2008	Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.	+	-	nl	Hypertension 51(6):1403-19 (2008) Calhoun DA
77	2006	Mechanisms of sympathetic activation in obesity-related hypertension.	+	-	nl	Hypertension 48(5):787-96 (2006) Esler M
78	2006	Have ALLHAT, ANBP2, ASCOT-BPLA, and so forth improved our knowledge about better hypertension care?	+	-	nl	Hypertension 48(1):1-7 (2006) Sawicki PT
79	2005	Angiotensin-converting enzyme inhibitors and calcium channel blockers for coronary heart disease and stroke prevention.	+	-	nl	Hypertension 46(2):386-92 (2005) Verdecchia P
80	2005	Management of prehypertension.	+	-	nl	Hypertension 45(6):1056-61 (2005) Svetkey LP
81	2005	Obesity-associated hypertension: new insights into mechanisms.	+	-	nl	Hypertension 45(1):9-14 (2005) Rahmouni K
82	1993	1993 guidelines for the management of mild hypertension. Memorandum from a World Health Organization/International Society of Hypertension meeting. Guidelines Subcommittee of the WHO/ISH Mild Hypertension Liaison Committee.	+	-	nl	Hypertension 22(3):392-403 (1993)
83	2006	Thiazide diuretics in the treatment of hypertension: an update.	+	-	nl	J Am Soc Nephrol 17(4 Suppl 2):S25-9 (2006) Salvetti A
84	1998	Malignant hypertension and hypertensive emergencies.	+	-	nl	J Am Soc Nephrol 9(1):133-42 (1998)
85	2008	Antihypertensive treatment and stroke prevention in patients with and without chronic kidney disease: a review of controlled trials.	+	-	nl	J Nephrol 21(3):374-83 (2008) Segall L
86	2006	Central arterial pressure and arterial pressure pulse: new views entering the second century after Korotkov.	+	-	nl	Mayo Clin Proc 81(8):1057-68 (2006) O'Rourke MF
87	2006	The role of combination therapy in the management of hypertension.	+	-	nl	Nephrol Dial Transplant 21(6):1469-73 (2006) Neutel JM
88	1997	Malignant hypertension: still a challenge.	+	-	nl	Nephrol Dial Transplant 12(9):2019-23 (1997)
89	2004	The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents.	+	-	nl	Pediatrics 114(2 Suppl 4th Report):555-76 (2004)
90	2003	Classification and definition of disorders causing hypertonia in childhood.	+	-	nl	Pediatrics 111(1):e89-97 (2003) Sanger TD
91	2004	Use of diuretics in cardiovascular disease: (2) hypertension.	+	-	nl	Postgrad Med J 80(943):271-6 (2004) Shah SU
92	1993	A risk-benefit analysis for the treatment of hypertension.	+	-	nl	Postgrad Med J 69(816):764-74 (1993)
93	1993	Noninvasive 24 hour ambulatory blood pressure monitoring: current status.	+	-	nl	Postgrad Med J 69(810):255-67 (1993)
94	1993	Paediatrics--Part I.	+	-	nl	Postgrad Med J 69(809):171-85 (1993)
95	1991	Hypertension.	+	-	nl	Postgrad Med J 67(785):230-46 (1991)
96	2005	Blood pressure reduction for vascular risk: is there a price to be paid?	+	-	nl	Stroke 36(6):1308-13 (2005) Birns J
97	2004	Blood pressure and stroke: an overview of published reviews.	+	-	nl	Stroke 35(3):776-85 (2004) Lawes CM
98	2003	Blood pressure-lowering for secondary prevention of stroke: ACE inhibition is the key.	+	-	nl	Stroke 34(5):1333-4 (2003) Anderson C
99	2003	Blood pressure-lowering for secondary prevention of stroke: ACE inhibition is not the key.	+	-	nl	Stroke 34(5):1334-5 (2003) Bath P
100	1991	Management of mild hypertension. Selecting an antihypertensive regimen.	+	-	nl	West J Med 154(1):78-87 (1991)
101	1984	Malignant or accelerated hypertension.	+	-	nl	West J Med 140(4):575-82 (1984)
102	1980	Antihypertensive pharmacology.	+	-	nl	West J Med 132(5):430-9 (1980)
103	1979	Nontraditional problems of antihypertensive management.	+	-	nl	West J Med 131(3):179-92 (1979)
104	2008	Resistant hypertension: an overview of evaluation and treatment.	+	-	nl	J Am Coll Cardiol 52(22):1749-57 (2008) Sarafidis PA
105	2007	Hypertension in the young: preventing the evolution of disease versus prevention of clinical events.	+	-	nl	J Am Coll Cardiol 50(9):840-2 (2007) Williams B
106	2005	Home blood pressure measurement: a systematic review.	+	-	nl	J Am Coll Cardiol 46(5):743-51 (2005) Verberk WJ
107	2005	Recent hypertension trials: implications and controversies.	+	-	nl	J Am Coll Cardiol 45(6):813-27 (2005) Williams B
108	2001	Pulse pressure--a review of mechanisms and clinical relevance.	+	-	nl	J Am Coll Cardiol 37(4):975-84 (2001)
109	1996	Primary renal abnormalities in hereditary hypertension.	+	-	nl	Kidney Int 50(3):717-31 (1996)
110	2001	Molecular mechanisms of human hypertension.	+	-	nl	Cell 104(4):545-56 (2001)
111	2006	Re-examining the efficacy of beta-blockers for the treatment of hypertension: a meta-analysis.	+	-	nl	CMAJ 174(12):1737-42 (2006) Khan N
112	2000	Choosing a first-line drug in the management of elevated blood pressure: what is the evidence? 2: Beta-blockers.	+	-	nl	CMAJ 163(2):188-92 (2000)
113	2000	Choosing a first-line drug in the management of elevated blood pressure: what is the evidence? 1: Thiazide diuretics.	+	-	nl	CMAJ 163(1):57-60 (2000)
114	1999	Systematic review of antihypertensive therapies: does the evidence assist in choosing a first-line drug?	+	-	nl	CMAJ 161(1):25-32 (1999)
115	1993	Integration of factors controlling vascular tone. Overview.	+	-	nl	Anesthesiology 79(6):1368-80 (1993)
116	1977	Psychological methods in treatment of hypertension: a review.	+	-	nl	Br Heart J 39(6):587-93 (1977)
117	1971	What is hypertension? Recent studies on neurogenic hypertension.	+	-	nl	Br Heart J 33(-):Suppl:109-12 (1971)
118	2003	Better blood pressure control: how to combine drugs.	+	-	nl	J Hum Hypertens 17(2):81-6 (2003) Brown MJ
119	2000	Hypertension and the prothrombotic state.	+	-	nl	J Hum Hypertens 14(10-11):687-90 (2000)
120	2000	Cerebral complications of hypertension.	+	-	nl	J Hum Hypertens 14(10-11):605-16 (2000)
121	1999	Clinical presentation and management of patients with uncontrolled, severe hypertension: results from a public teaching hospital.	+	-	nl	J Hum Hypertens 13(4):249-55 (1999)
122	1998	Isolated systolic hypertension: pathophysiology, consequences and therapeutic benefits.	+	-	nl	J Hum Hypertens 12(9):621-6 (1998)
123	1998	Secondary hypertension in the elderly.	+	-	nl	J Hum Hypertens 12(9):603-6 (1998)
124	2007	Recent update in the management of hypertension.	+	-	nl	Acta Med Indones 39(4):186-91 (2007)
125	2010	Pivotal role of the kidney in hypertension.	+	-	nl	Am J Med Sci 340(1):30-2 (2010)
126	2007	NKCC1 as a regulator of vascular tone and a novel target for antihypertensive therapeutics.	+	-	nl	Am J Physiol Heart Circ Physiol 292(5):H2035-6 (2007) Orlov SN
127	2008	The beginning of a fantastic, unanswered question: is 5-HT involved in systemic hypertension?	+	-	nl	Am J Physiol Heart Circ Physiol 295(3):H915-H916 (2008)
128	2009	A new piece in the hypertension puzzle: central blood pressure regulation by sex steroids.	+	-	nl	Am J Physiol Heart Circ Physiol 297(5):H1583-4 (2009) Yanes LL
129	2009	Angiotensin II, mechanotransduction, and pulsatile arterial hemodynamics in hypertension.	+	-	nl	Am J Physiol Heart Circ Physiol 297(5):H1567-75 (2009)
130	2010	Endogenous cardiotonic steroids and salt-sensitive hypertension.	+	-	nl	Biochim Biophys Acta 1802(12):1230-6 (2010)
131	2010	Genetics of hypertension: from experimental animals to humans.	+	-	nl	Biochim Biophys Acta 1802(12):1299-308 (2010)
132	2007	TRP channels in hypertension.	+	-	nl	Biochim Biophys Acta 1772(8):895-906 (2007)
133	2010	The effects of biofeedback in diabetes and essential hypertension.	+	-	nl	Cleve Clin J Med 77 Suppl 3(-):S68-71 (2010)
134	2011	Goal-directed antihypertensive therapy: lower may not always be better.	+	-	nl	Cleve Clin J Med 78(2):123-33 (2011)
135	2009	Beyond office sphygmomanometry: ways to better assess blood pressure.	+	-	nl	Cleve Clin J Med 76(11):657-62 (2009) Rafey M
136	2010	Management of high blood pressure in Blacks: an update of the International Society on Hypertension in Blacks consensus statement.	+	-	nl	Hypertension 56(5):780-800 (2010) Flack JM
137	2010	Morning surge in blood pressure and cardiovascular risk: evidence and perspectives.	+	-	nl	Hypertension 56(5):765-73 (2010)
138	2010	Salt and aldosterone: a concert of bad effects.	+	-	nl	Hypertension 56(5):804-5 (2010)
139	2010	DORADO: opportunity postponed: lessons from studies of endothelin receptor antagonists in treatment-resistant hypertension.	+	-	nl	Hypertension 56(5):806-7 (2010)
140	2010	Sympathetic nervous activation in essential hypertension: commonly neglected as a therapeutic target, usually ignored as a drug side effect.	+	-	nl	Hypertension 55(5):1090-1 (2010)
141	2010	Drug combinations in the treatment of hypertension: never-ending novelty.	+	-	nl	Hypertension 56(1):22-3 (2010)
142	2010	Strategies and goals for hypertension control in patients with diabetes mellitus.	+	-	nl	Hypertension 56(1):24-5 (2010)
143	2010	Sympathetic nervous system and blood pressure in humans: individualized patterns of regulation and their implications.	+	-	nl	Hypertension 56(1):10-6 (2010)
144	2010	Electrical carotid baroreceptor stimulation in resistant hypertension.	+	-	nl	Hypertension 55(3):607-9 (2010)
145	2010	Mineralocorticoid receptors, salt-sensitive hypertension, and metabolic syndrome.	+	-	nl	Hypertension 55(4):813-8 (2010)
146	2010	Implications of recently published trials of blood pressure-lowering drugs in hypertensive or high-risk patients.	+	-	nl	Hypertension 55(4):819-31 (2010)
147	2010	Unresolved issues in the management of hypertension.	+	-	nl	Hypertension 55(4):832-4 (2010) Yusuf S
148	2008	Transient receptor potential vanilloid type 1 receptors in hypertensive renal damage: a promising therapeutic target?	+	-	nl	Hypertension 52(2):213-4 (2008)
149	2004	Novel mechanisms responsible for postmenopausal hypertension.	+	-	nl	Hypertension 43(5):918-23 (2004)
150	2004	Hypertension and cyclooxygenase-2 inhibitors: target: the renal medulla.	+	-	nl	Hypertension 44(4):396-7 (2004) Hao CM
151	2004	Alcohol-associated hypertension: when one drinks makes a difference.	+	-	nl	Hypertension 44(6):805-6 (2004) Klatsky AL
152	2009	The pump, the exchanger, and endogenous ouabain: signaling mechanisms that link salt retention to hypertension.	+	-	nl	Hypertension 53(2):291-8 (2009)
153	2009	Mitochondrial dysfunction and mitochondrial-produced reactive oxygen species: new targets for neurogenic hypertension?	+	-	nl	Hypertension 53(2):112-4 (2009)
154	2009	Cardiovascular protection with antihypertensive drugs in dialysis patients: systematic review and meta-analysis.	+	-	nl	Hypertension 53(5):860-6 (2009)
155	2007	Treating resistant hypertension with a neglected old drug.	+	-	nl	Hypertension 49(4):763-4 (2007)
156	2007	Do statins reduce blood pressure?: a meta-analysis of randomized, controlled trials.	+	-	nl	Hypertension 49(4):792-8 (2007)
157	2005	Adducin polymorphism: detection and impact on hypertension and related disorders.	+	-	nl	Hypertension 45(3):331-40 (2005)
158	2005	Systematic review of combined angiotensin-converting enzyme inhibition and angiotensin receptor blockade in hypertension.	+	-	nl	Hypertension 45(5):880-6 (2005)
159	2005	Baroreflex failure.	+	-	nl	Hypertension 45(5):834-9 (2005)
160	2009	Postmenopausal hypertension: mechanisms and therapy.	+	-	nl	Hypertension 54(1):11-8 (2009)
161	2009	Mitochondrial Thioredoxin: novel regulator for NADPH oxidase and angiotensin II-induced hypertension.	+	-	nl	Hypertension 54(2):224-5 (2009)
162	2009	Assessment of sympathetic cardiovascular drive in human hypertension: achievements and perspectives.	+	-	nl	Hypertension 54(4):690-7 (2009)
163	2005	The kidney as a determinant of genetic hypertension: evidence from renal transplantation studies.	+	-	nl	Hypertension 46(3):463-8 (2005)
164	2005	Neurogenic mechanisms and salt sensitivity.	+	-	nl	Hypertension 46(6):1259-60 (2005)
165	2005	Baroreflexes in hypertension: a mystery revisited.	+	-	nl	Hypertension 46(5):1095-6 (2005)
166	2008	A tale of two patients with Mendelian hypertension.	+	-	nl	Hypertension 51(3):609-14 (2008)
167	2008	Pathogenesis of elevated peripheral pulse pressure: some reflections and thinking forward.	+	-	nl	Hypertension 51(1):33-6 (2008) Vasan RS
168	2008	Should we target the sympathetic nervous system in the treatment of obesity-associated hypertension?	+	-	nl	Hypertension 51(2):168-71 (2008)
169	2008	Update on the use of antihypertensive drugs in pregnancy.	+	-	nl	Hypertension 51(4):960-9 (2008)
170	2008	Aminopeptidase A: could it be a novel target for neurogenic hypertension?	+	-	nl	Hypertension 51(5):1273-4 (2008) Ferreira AJ
171	2008	G protein-coupled receptor kinase 4: role in blood pressure regulation.	+	-	nl	Hypertension 51(6):1449-55 (2008)
172	2008	Kidney in hypertension: guyton redux.	+	-	nl	Hypertension 51(4):811-6 (2008)
173	2008	Pediatric antihypertensive trial failures: analysis of end points and dose range.	+	-	nl	Hypertension 51(4):834-40 (2008)
174	2008	Kidney and circadian blood pressure rhythm.	+	-	nl	Hypertension 51(4):827-8 (2008)
175	2005	Vascular development, pulse pressure, and the mechanisms of hypertension.	+	-	nl	Hypertension 46(1):205-9 (2005)
176	2009	Renal denervation as a therapeutic approach for hypertension: novel implications for an old concept.	+	-	nl	Hypertension 54(6):1195-201 (2009)
177	2009	Another major role for dietary sodium reduction: improving blood pressure control in patients with resistant hypertension.	+	-	nl	Hypertension 54(3):444-6 (2009)
178	2010	RGS2 proteins regulate blood pressure.	+	-	nl	J Am Soc Nephrol 21(11):1809-10 (2010) Welch WJ
179	2004	Overview: mechanisms of hypertension: cells, hormones, and the kidney.	+	-	nl	J Am Soc Nephrol 15(8):1971-3 (2004)
180	2003	Prevention of hypertension and its complications: theoretical basis and guidelines for treatment.	+	-	nl	J Am Soc Nephrol 14(7 Suppl 2):S92-8 (2003)
181	2005	Prenatal programming of hypertension: lessons from experimental models.	+	-	nl	J Am Soc Nephrol 16(9):2545-56 (2005)
182	2007	Salt-sensitive hypertension--update on novel findings.	+	-	nl	Nephrol Dial Transplant 22(4):992-5 (2007)
183	2010	Hypertension in children and adolescents: epidemiology and natural history.	+	-	nl	Pediatr Nephrol 25(7):1219-24 (2010)
184	2009	At the bottom of the differential diagnosis list: unusual causes of pediatric hypertension.	+	-	nl	Pediatr Nephrol 24(11):2137-46 (2009)
185	2009	Treatment of hypertension in children and adolescents.	+	-	nl	Pediatr Nephrol 24(10):1939-49 (2009)
186	2009	Heritable forms of hypertension.	+	-	nl	Pediatr Nephrol 24(10):1929-37 (2009)
187	2010	Neural set point for the control of arterial pressure: role of the nucleus tractus solitarius.	+	-	nl	Biomed Eng Online 9(-):4 (2010)
188	2010	The search for strategies to control hypertension.	+	-	nl	Circulation 122(12):1141-3 (2010)
189	2003	Morning surge in blood pressure.	+	-	nl	Circulation 107(10):1347 (2003)
190	2005	Diuretics for hypertension.	+	-	nl	Circulation 112(10):e127-9 (2005)
191	2011	Mevalonate pathway is a novel target for hypertension.	+	-	nl	Circ J 75(6):1318-9 (2011) Kishi T
192	2011	Transient receptor potential melastatin 7 (TRPM7) cation channels, magnesium and the vascular system in hypertension.	+	-	nl	Circ J 75(2):237-45 (2011)
193	2010	Sympathoinhibitory effects of atorvastatin in hypertension.	+	-	nl	Circ J 74(12):2552-3 (2010) Kishi T
194	2009	Orthostatic hypertension: a measure of blood pressure variation for predicting cardiovascular risk.	+	-	nl	Circ J 73(6):1002-7 (2009)
195	2003	Intrauterine undernutrition--renal and vascular origin of hypertension.	+	-	nl	Cardiovasc Res 60(2):228-34 (2003)
196	2008	The regulation of salt transport and blood pressure by the WNK-SPAK/OSR1 signalling pathway.	+	-	nl	J Cell Sci 121(Pt 20):3293-304 (2008)
197	2010	Epithelial Na+ channel (ENaC), hormones, and hypertension.	+	-	nl	J Biol Chem 285(31):23527-31 (2010)
198	2010	Role of epithelial sodium channels and their regulators in hypertension.	+	-	nl	J Biol Chem 285(40):30363-9 (2010)
199	2009	Management of blood pressure for acute and recurrent stroke.	+	-	nl	Stroke 40(6):2251-6 (2009)
200	2010	Blood pressure in young adults.	+	-	nl	Rev Port Cardiol 29(10):1495-508 (2010)
201	2010	High blood pressure in the pediatric age group.	+	-	nl	Rev Port Cardiol 29(3):413-32 (2010)
202	2005	Hypertension in children and adolescents.	+	-	nl	Rev Port Cardiol 24(9):1091-4 (2005)
203	2008	Some reflections on prehypertension.	+	-	nl	Rev Port Cardiol 27(12):1583-9 (2008)
204	2008	Malignant hypertension, severe hypertensive retinopathy and malignant nephroangiosclerosis.	+	-	nl	Rev Port Cardiol 27(3):373-9 (2008)
205	2009	Update in primary aldosteronism.	+	-	nl	J Clin Endocrinol Metab 94(10):3623-30 (2009)
206	2010	Hyperosmotic activation of CNS sympathetic drive: implications for cardiovascular disease.	+	-	nl	J Physiol 588(Pt 18):3375-84 (2010)
207	2006	Topics on the Na+/Ca2+ exchanger: role of vascular NCX1 in salt-dependent hypertension.	+	-	nl	J Pharmacol Sci 102(1):32-6 (2006)
208	2009	Dinucleoside polyphosphates: strong endogenous agonists of the purinergic system.	+	-	nl	Br J Pharmacol 157(7):1142-53 (2009)
209	2009	Endothelium-dependent contractions and endothelial dysfunction in human hypertension.	+	-	nl	Br J Pharmacol 157(4):527-36 (2009)
210	2004	Salt handling and hypertension.	+	-	nl	J Clin Invest 113(8):1075-81 (2004)
211	2005	Links between dietary salt intake, renal salt handling, blood pressure, and cardiovascular diseases.	+	-	nl	Physiol Rev 85(2):679-715 (2005)
212	2009	Physiological significance of heme oxygenase in hypertension.	+	-	nl	Int J Biochem Cell Biol 41(5):1025-33 (2009)
213	2011	Treatment strategies for resistant arterial hypertension.	+	-	nl	Dtsch Arztebl Int 108(43):725-31 (2011)
214	2005	Abnormalities of the resistance vasculature in hypertension: correction by vasodilator therapy.	+	-	nl	Pharmacol Rep 57 Suppl(-):144-50 (2005)
215	2008	Angiotensin II type 1 receptor blocker combined with hydrochlorothiazide for the treatment of hypertension.	+	-	nl	Intern Med 47(13):1163-4 (2008)
216	2004	Systolic hypertension in older persons.	+	-	nl	JAMA 292(9):1074-80 (2004)
217	2004	The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.	+	-	nl	Can J Cardiol 20(1):41-54 (2004)
218	2004	The 2004 Canadian recommendations for the management of hypertension: Part III--Lifestyle modifications to prevent and control hypertension.	+	-	nl	Can J Cardiol 20(1):55-9 (2004)
219	2004	The 2004 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I--Blood pressure measurement, diagnosis and assessment of risk.	+	-	nl	Can J Cardiol 20(1):31-40 (2004)
220	2003	Potential role of lysophosphatidic acid in hypertension and atherosclerosis.	+	-	nl	Can J Cardiol 19(13):1525-36 (2003)
221	2007	Night-time blood pressure patterns and target organ damage: a review.	+	-	nl	Can J Cardiol 23(2):132-8 (2007)
222	2007	The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 1- blood pressure measurement, diagnosis and assessment of risk.	+	-	nl	Can J Cardiol 23(7):529-38 (2007) Padwal RS
223	2007	The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.	+	-	nl	Can J Cardiol 23(7):539-50 (2007) Khan NA
224	2007	More medications, fewer pills: combination medications for the treatment of hypertension.	+	-	nl	Can J Cardiol 23(7):573-6 (2007)
225	2007	Treatment of hypertension in patients with nondiabetic chronic kidney disease.	+	-	nl	Can J Cardiol 23(7):595-601 (2007)
226	2007	Musings regarding hypertension.	+	-	nl	Can J Cardiol 23(7):603-4 (2007)
227	2009	Resistant hypertension.	+	-	nl	Can J Cardiol 25(5):315-7 (2009)
228	2009	2009 Canadian Hypertension Education Program recommendations: the scientific summary--an annual update.	+	-	nl	Can J Cardiol 25(5):271-7 (2009)
229	2009	The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1--blood pressure measurement, diagnosis and assessment of risk.	+	-	nl	Can J Cardiol 25(5):279-86 (2009)
230	2009	The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2--therapy.	+	-	nl	Can J Cardiol 25(5):287-98 (2009)
231	2009	Hypertension in diabetes: a call to action.	+	-	nl	Can J Cardiol 25(5):299-302 (2009)
232	2009	Hypertension in dialysis and kidney transplant patients.	+	-	nl	Can J Cardiol 25(5):309-14 (2009)
233	2008	The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.	+	-	nl	Can J Cardiol 24(6):465-75 (2008)
234	2008	The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1 - blood pressure measurement, diagnosis and assessment of risk.	+	-	nl	Can J Cardiol 24(6):455-63 (2008)
235	2010	Diagnostic modalities of the most common forms of secondary hypertension.	+	-	nl	Hellenic J Cardiol 51(6):518-29 (2010)
236	2008	Beta-blockers in the treatment of hypertension: latest data and opinions.	+	-	nl	Hellenic J Cardiol 49(1):37-47 (2008)
237	2010	Strategies for initial management of hypertension.	+	-	nl	Indian J Med Res 132(5):531-42 (2010)
238	2010	Aliskiren and valsartan combination therapy for the management of hypertension.	+	-	nl	Vasc Health Risk Manag 6(-):711-22 (2010)
239	2011	Effect of melatonin on nocturnal blood pressure: meta-analysis of randomized controlled trials.	+	-	nl	Vasc Health Risk Manag 7(-):577-84 (2011)
240	2011	Treatment options for hypertension in high-risk patients.	+	-	nl	Vasc Health Risk Manag 7(-):137-41 (2011)
241	2011	Olmesartan/amlodipine: a review of its use in the management of hypertension.	+	-	nl	Vasc Health Risk Manag 7(-):183-92 (2011)
242	2007	Summary of the 2007 European Society of Hypertension (ESH) and European Society of Cardiology (ESC) guidelines for the management of arterial hypertension.	+	-	nl	Vasc Health Risk Manag 3(6):783-95 (2007)
243	2010	The 'neuroadrenergic hypothesis' in hypertension: current evidence.	+	-	nl	Exp Physiol 95(5):581-6 (2010)
244	2005	Sympatho-renal interactions in the determination of arterial pressure: role in hypertension.	+	-	nl	Exp Physiol 90(2):183-7 (2005)
245	2005	Role of leptin in obesity-related hypertension.	+	-	nl	Exp Physiol 90(5):683-8 (2005)
246	2008	A sympathetic view of the sympathetic nervous system and human blood pressure regulation.	+	-	nl	Exp Physiol 93(6):715-24 (2008)
247	2010	Redox unbalance: NADPH oxidase as therapeutic target in blood pressure control.	+	-	nl	Arq Bras Cardiol 94(5):643-51, 684-93 (2010)
248	2007	Occurrence rate and clinical predictors of hypertensive pseudocrisis in emergency room care.	+	-	nl	Arq Bras Cardiol 88(5):579-84 (2007)
249	2007	Mechanisms and treatment of resistant hypertension.	+	-	nl	Arq Bras Cardiol 88(6):683-92 (2007)
250	2011	Dutch guideline for the management of hypertensive crisis -- 2010 revision.	+	-	nl	Neth J Med 69(5):248-55 (2011)
251	2010	Hypertension in pediatric patients.	+	-	nl	Indian Pediatr 47(6):473-4 (2010)
252	2006	Childhood hypertension.	+	-	nl	Indian Pediatr 43(4):326-33 (2006)
253	2007	Evaluation and management of hypertension.	+	-	nl	Indian Pediatr 44(2):103-21 (2007)
254	2004	Genetics of essential hypertension.	+	-	nl	Hum Mol Genet 13 Spec No 1(-):R169-75 (2004)
255	2007	Genetic basis of polygenic hypertension.	+	-	nl	Hum Mol Genet 16 Spec No. 2(-):R195-202 (2007)
256	2011	Hypertension in people with type 2 diabetes: Update on pharmacologic management.	+	-	nl	Can Fam Physician 57(9):997-1002, e347-53 (2011)
257	2010	Role of the kidney in the prenatal and early postnatal programming of hypertension.	+	-	nl	Am J Physiol Renal Physiol 298(2):F235-47 (2010)
258	2008	Programming of hypertension: the nervous kidney.	+	-	nl	Am J Physiol Renal Physiol 295(1):F27-8 (2008) Vehaskari VM
259	2010	The evidence-based use of thiazide diuretics in hypertension and nephrolithiasis.	+	-	nl	Clin J Am Soc Nephrol 5(10):1893-903 (2010)
260	2007	Resistant hypertension: a methodological approach to diagnosis and treatment.	+	-	nl	Saudi J Kidney Dis Transpl 18(3):337-45 (2007)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.